Beta Bionics price to book ratio BBNX
Market value divided by the book value of the company's net assets, since 2025.
- Today, Nov 2, 2026
- 2.2×
- Peer median
- 2.9×
Beta Bionics' price to book ratio is 2.2× as of Nov 2, 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 2.9×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 2.2× | 1.4× | 4.4× |
| 2025 | 4.8× | 1.8× | 4.8× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Beta Bionics' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| BBNXBeta Bionics | 2.2× |
| IRMDIradimed | 9.5× |
| MOVMovado | 1.4× |
| IARTIntegra Lifesciences | 1.0× |
| BVSBioventus | 4.8× |
| STAAStaar Surgical | 3.4× |
| CDRECadre | 3.9× |
| EYENational Vision | 1.5× |
| TCMDTactile Systems Technology | 2.3× |
| LMATLemaitre Vascular | 4.4× |
| INSPInspire Medical Systems | 2.4× |
| Peer median | 2.9× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Beta Bionics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.